Arthur Fratamico

Arthur Fratamico

Director/Board Member at SUN BIOPHARMA INC
61 year
Health Technology
Consumer Services

Profile

Arthur J.
Fratamico
is currently an Independent Director at Panbela Therapeutics, Inc., a position held since 2019.
Formerly, Mr. Fratamico was President & Chief Executive Officer at Radiant Biotherapeutics, Inc., Vice President-Business Development & Licensing at MGI PHARMA, Inc., Chief Business Officer at Flexion Therapeutics, Inc. from 2012 to 2014, Chief Business Officer at Vitae Pharmaceuticals LLC from 2014 to 2016, Vice President-Business & Strategic Development at Gemin X Pharmaceuticals US, Inc. from 2009 to 2010, Principal at Hoechst Marion Roussel, Inc., Chief Business Officer at Trevena, Inc., and Chief Business Officer at Galera Therapeutics, Inc. Education includes an MBA from Drexel University and undergraduate studies at Philadelphia College of Pharmacy.

Arthur Fratamico active positions

CompaniesPositionStart
SUN BIOPHARMA INC Director/Board Member 16/12/2019

Former positions of Arthur Fratamico

CompaniesPositionEnd
VITAE PHARMACEUTICALS INC Corporate Officer/Principal 25/12/2016
FLEXION THERAPEUTICS, INC. Corporate Officer/Principal 01/01/2014
Chief Executive Officer -
GALERA THERAPEUTICS, INC. Corporate Officer/Principal -
TREVENA, INC. Corporate Officer/Principal -
See the detail of Arthur Fratamico's experience

Training of Arthur Fratamico

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

29

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Arthur Fratamico
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!